New Data Affirms Strength of UCB Immuno-Dermatology Portfolio

Friday, March 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Corporate Communications

 

France Nivelle,                  Global Communications, UCB

T +32.2.559.9178, france.nivelle@ucb.com  

Investor Relations

 

Antje Witte,                      Investor Relations, UCB

T +32.2.559.94.14, antje.witte@ucb.com

Brand Communications

 

Andrea Levin Christopher,Immunology Communications, UCB

T +1.404.483.7329

andrea.christopher@ucb.com

Laurent Schots,

Media Relations, UCB   

T+32.2.559.92.64, laurent.schots@ucb.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store